* Lifestance Health Group Inc LFST.OQ LFST.O is expected
to show a rise in quarterly revenue when it reports results on
November 8.
* The Scottsdale Arizona-based company is expected to
report a
26.4% increase in revenue to $219.649 million from $173.84
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Lifestance Health
Group
Inc is for a loss of 14 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Lifestance
Health
Group Inc is $9, above its last closing price of $7.25.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.15 -0.14 -0.19 Missed -35.7
Mar. 31 2022 -0.20 -0.17 -0.18 Missed -4.7
Dec. 31 2021 -0.20 -0.21 -0.33 Missed -55.9
Sep. 30 2021 -0.24 -0.24 -0.35 Missed -45.8
Jun. -0.14 -0.14 -0.22 Missed -57.1
30 2021
This summary was machine generated November 5 at 02:45 GMT. All
figures in US dollars unless otherwise stated